Sk Biopharmaceuticals Co Ltd (326030) — Financial Flexibility Index
Sk Biopharmaceuticals Co Ltd (326030) has a Financial Flexibility Index of 0.31x as of December 2025. Free cash flow of ₩113.55 Billion (operating CF ₩87.00 Billion minus capex ₩26.55 Billion) represents 0% of total liabilities (₩372.04 Billion). Also explore net asset momentum of Sk Biopharmaceuticals Co Ltd to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Sk Biopharmaceuticals Co Ltd Financial Flexibility Index (2016–2025)
Historical Financial Flexibility Index trend for Sk Biopharmaceuticals Co Ltd across 10 annual periods. Check Sk Biopharmaceuticals Co Ltd strategic asset allocation index to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Sk Biopharmaceuticals Co Ltd (2016–2025)
Year-by-year free cash flow to debt coverage for Sk Biopharmaceuticals Co Ltd. For the full company profile including market capitalisation, see market value of Sk Biopharmaceuticals Co Ltd.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | ₩205.84 Billion | ₩176.33 Billion | ₩372.04 Billion | ▲ +136.4% |
| 2024 | 0.23x | ₩108.32 Billion | ₩94.90 Billion | ₩462.83 Billion | ▲ +203.5% |
| 2023 | -0.23x | ₩-90.95 Billion | ₩-94.20 Billion | ₩402.22 Billion | ▲ +49.3% |
| 2022 | -0.45x | ₩-155.01 Billion | ₩-159.92 Billion | ₩347.68 Billion | ▼ -0.4% |
| 2021 | -0.44x | ₩-88.56 Billion | ₩-92.87 Billion | ₩199.46 Billion | ▲ +73.1% |
| 2020 | -1.65x | ₩-199.70 Billion | ₩-210.73 Billion | ₩121.17 Billion | ▼ -272.5% |
| 2019 | -0.44x | ₩-67.29 Billion | ₩-81.33 Billion | ₩152.10 Billion | ▲ +88.3% |
| 2018 | -3.79x | ₩-139.85 Billion | ₩-141.28 Billion | ₩36.91 Billion | ▼ -100.3% |
| 2017 | -1.89x | ₩-96.70 Billion | ₩-98.34 Billion | ₩51.12 Billion | ▼ -117.7% |
| 2016 | -0.87x | ₩-40.14 Billion | ₩-48.94 Billion | ₩46.21 Billion | — |